1. 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results. (December 2022) Authors: Cheng, Y.; Wang, J.; Yu, Y.; Zang, A.; Lv, D.; Li, S.; Cao, L.; Meng, Z.; Mao, W.D.; Zhang, J.; Liu, A.; Zhang, Y.; Tang, K.; Liu, J.; Zheng, J.; Wang, Z.; Chen, E.; Zhang, X.; Guo, Q.; Huang, D. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 135P Camrelizumab plus chemotherapy as first-line therapy for NSCLC: A pooled analysis of two randomized phase III trials with extended follow-up. (December 2022) Authors: Zhou, C.; Chen, G.; Huang, Y.; Chen, J.; Cheng, Y.; Wang, Q.; Pan, Y.; Zhou, J.; Shi, J.; Xu, X.; Lin, L.; Zhang, W.; Zhang, Y.; Liu, Y.; Fang, Y.; Feng, J.; Wang, Z.; Tai, Y.; Ma, X.; Lu, X. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 164P TQB2450 plus anlotinib combined with paclitaxel and cisplatin as first-line treatment of advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicenter phase Ⅱ trial. (December 2022) Authors: Wang, J.; Li, N.; Guo, Y.; Cheng, Y.; Li, B.; Luo, S. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1T/2H mixed phase MoS2 in-situ grown on the surface of montmorillonite for selectively removing Pb2+. (June 2022) Authors: Cheng, Y.; Yang, S.; E, Tao; Liu, L.; Wang, D.; Qian, J. Journal: Materials today chemistry Issue: Volume 24(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 70P A retrospective real-world study of anlotinib plus PD-1 inhibitors in advanced esophageal squamous cell carcinoma (ESCC) previously treated with immune checkpoint inhibitors (ICIs). (December 2022) Authors: Liu, J.; Zhu, X.; Cheng, Y.; Li, H.; Ma, X.; Fu, X. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC). (December 2022) Authors: Cheng, Y.; Liu, B.; Wu, L.; Zhang, T.; Wang, K.; L. Miao, ; Wu, J.; Wang, H.; Fang, J.; Li, X.; Zhang, W.; Hu, Y.; Mei, X.; Song, Y.; Wu, C.; Zhu, J.; Xin, Y.; Chen, Y.; Han, G.; Ye, J. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 81P Is PD-1 inhibitor based treatment better than chemotherapy for metastatic NSCLC patients with PD-L1≥50% who develop EGFR-TKI resistance? A real-world investigation. (December 2022) Authors: Li, Y.; Jiang, H.; Qian, F.; Cheng, Y.; Zhang, Y.; Lu, J.; Lou, Y.; Han, B.; Zhang, W. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. [BP.09.03] ASSOCIATION OF CIRCULATING OSTEOPROTEGERIN (OPG) AND RANKL WITH INTRACRANIAL ARTERIAL CALCIFICATION IN HYPERTENSIVE PATIENTS. (September 2017) Authors: Cheng, Y.; Wang, Y.; Guo, Q.; Zhu, D.; Li, Y. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A 3-parameter Gompertz distribution for survival data with competing risks, with an application to breast cancer data. Issue 12 (9th September 2016) Authors: Haile, S. R.; Jeong, J.-H.; Chen, X.; Cheng, Y. Journal: Journal of applied statistics Issue: Volume 43:Issue 12(2016) Page Start: 2239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Framework for Fracture Extraction Under Glaciological Property‐Based Constraints: Scientific Application on the Filchner–Ronne Ice Shelf of Antarctica. Issue 8 (29th August 2022) Authors: lv, D.; Cheng, Y.; Xiao, H.; Hai, G. Journal: Earth and space science Issue: Volume 9:Issue 8(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗